Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 277 clinical trials
Featured trial
Inflammatory Characterization of Known or Possible Cardiovascular Diseases

Background: Cardiometabolic diseases are a combination of medical disorders that, when they occur together, increase the risk of heart disease and diabetes. Researchers want to learn if there is a relationship between these diseases and inflammation (redness, swelling, and pain). Inflammation affects the entire body. Researchers will study this relationship …

heart disease
fats
diabetes
  • 163 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative

Background: Cardiometabolic diseases are medical disorders that can occur together and affect the heart. They increase the risk of developing heart disease and diabetes. One disorder, psoriasis, is an inflammation that mostly affects the skin but can affect the entire body. Another disorder, atherosclerosis, is a process in which cholesterol …

cholesterol measurement
diabetes
atherosclerosis
heart disease
  • 95 views
  • 23 Nov, 2020
  • 1 location
Featured trial
FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk

FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk

  • 268 views
  • 25 Mar, 2021
  • 1 location
Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

The purpose of AROANG3-2001 is to evaluate the efficacy and safety of ARO-ANG3 in participants with mixed dyslipidemia. Participants will receive 2 subcutaneous injections of ARO-ANG3 or placebo

  • 1 views
  • 06 Jan, 2022
  • 35 locations
Study of ARO-APOC3 in Adults With Mixed Dyslipidemia (MUIR)

Participants who have met all protocol eligibility criteria will be randomly assigned to treatment (ARO-APOC3 or placebo) in a double-blind fashion and will be evaluted for safety and efficacy over 48 weeks. Participants will be counseled to remain on a specified diet throughout the study, as recommended by the Investigator …

  • 0 views
  • 19 Apr, 2022
  • 28 locations
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

The purpose of this study is to evaluate the efficacy of Cipros 20 association in the treatment of dyslipidemia treatment.

  • 0 views
  • 06 Mar, 2021
  • 1 location
A Study of AZD8233 in Participants With Dyslipidemia. (HAYATE)

A Phase 1 and 2 Study of AZD8233 in Participants with Dyslipidemia and this study consists of Part A , Part B and Part C. Part A is designed as a randomized, single-blind (blinding of

body mass index
hmg-coa reductase inhibitors
statin therapy
fasting
  • 4 views
  • 30 Apr, 2022
  • 5 locations
A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

In order to study the effect of resveratrol on the improvement of lipid metabolism, randomized intervention trials were conducted to compare the effects of resveratrol on the improvement of lipid metabolism in different dose groups. To explore the best dose of resveratrol for the prevention and treatment of metabolic diseases …

Accepts healthy volunteers
  • 0 views
  • 05 Oct, 2021
  • 1 location
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

profile of patients with type 2 diabetes and dyslipidemia.

Accepts healthy volunteers
  • 0 views
  • 09 Mar, 2022
  • 1 location
Survival Benefits of Statins in Breast Cancer Patients (SBSBC)

In this study, we compared the survival benefit of breast cancer patients with dyslipidemia (low and medium risk of ASCVD). The control group used dietary intervention instead of statins

invasive breast cancer
cancer
breast cancer
  • 5 views
  • 09 Feb, 2022
  • 1 location